On February 4, Lujian Technology Health Technology Co., Ltd. officially signed an exclusive cooperation agreement with Israel’s Earways Medical Ltd., becoming the exclusive operator of the EarWay® earwax removal device. Leveraging its professional medical device CDMO platform within its ecosystem—Sichuan Innovation Technology Co., Ltd.—Lujian Technology is driving full-chain localization from R&D upgrading and technology transfer to production, accelerating the product’s commercialization in China.
Cerumen impaction is a common clinical ENT problem, and traditional treatments often suffer from low efficiency, high risk, and slow results. EarWay®, a medical device with FDA and CE dual certification, offers a safe, simple, and efficient solution for earwax removal. Its core device patent has been approved in multiple jurisdictions including the U.S., EU, Israel, China, and the U.K., establishing a strong global IP barrier. The product is already commercially available in the U.S., Canada, U.K., Australia, and other countries.
As an exclusive innovative device, EarWay® leverages its unique technological pathway to fill the domestic gap in earwax removal. Clinical data show that EarWay® achieves over 90% removal success and more than 95% safety, significantly reducing treatment time and lowering referral-related medical costs. It is suitable for primary care facilities, ENT specialty clinics, and home care scenarios.
This cooperation represents another key step in Lujian Technology’s international product strategy and underscores the company’s focus on innovative medical devices and technologies. A company spokesperson stated: “EarWay® is not only technologically mature but also aligns perfectly with China’s national healthcare ‘Strong Foundation Project’ policy to promote suitable technologies at the grassroots level. We will accelerate product registration, capacity building, and market entry to bring this efficient solution to Chinese patients as soon as possible, enhancing ENT diagnostic and treatment capabilities.”
As a company focused on global introduction and localization of high-end medical devices, Qingdao Lujian continues to build full-chain capabilities covering technology introduction, regulatory compliance, and production transformation. The introduction of EarWay® further enriches the company’s innovative product pipeline and injects new momentum into its integrated ecosystem “from introduction to manufacturing to service.”
WeChat Official Account |
Video Channel |
